Literature DB >> 3281698

Hexose metabolism in pancreatic islets: regulation of mitochondrial hexokinase binding.

F Malaisse-Lagae1, W J Malaisse.   

Abstract

A major fraction of hexokinase was found to be bound, presumably to mitochondria, in both normal and tumoral rat pancreatic islet cells examined after either mechanical disruption or digitonin treatment. Spermidine enhanced the binding and glucose 6-phosphate caused the release of hexokinase to and from islet mitochondria, in a manner comparable to that seen in parotid or brain homogenates. In hepatocytes, some hexokinase, but no glucokinase, was found in the bound form. In islet cells, however, the pattern of glucokinase binding was similar to that of hexokinase. It is speculated that the preferential location of both hexokinase and glucokinase on mitochondria may favor the maintenance of a high cytosolic ATP content in islet cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281698     DOI: 10.1016/0885-4505(88)90061-8

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  4 in total

Review 1.  Microcompartmentation of energy metabolism at the outer mitochondrial membrane: role in diabetes mellitus and other diseases.

Authors:  E R McCabe
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

Review 2.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

3.  Subcellular distribution of hexokinase isoenzymes in pancreatic islet cells exposed to digitonin after incubation at a low or high concentration of D-glucose.

Authors:  C Vanhoutte; A Sener; W J Malaisse
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

Review 4.  Mitochondrial DNA mutations in diseases of energy metabolism.

Authors:  D C Wallace
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.